FDA approves most expensive drug ever, a $3.5 million-per-dose gene therapy for hemophilia B
Washington — U.S. wellness regulators on Tuesday approved the initially gene treatment for hemophilia, a $3.5 million just one-time therapy for the blood-clotting condition. The Food items and Drug Administration cleared…






